July 2015

Entyvio by Takeda Pharmaceuticals

July 10, 2015

Formulary Drug Review

Entyvio, manufactured by Takeda Pharmaceuticals, was approved in May 2014 for the treatment of adult patients with moderate to severe ulcerative colitis or Crohn's disease.